Chan K M, Delfert D M, Koepnick S L, McDonald J M
Arch Biochem Biophys. 1987 Aug 1;256(2):472-9. doi: 10.1016/0003-9861(87)90604-7.
In an initial attempt to use calmodulin antagonists as probes to study the role of calmodulin in the modulation of Ca2+ uptake activity in the endoplasmic reticulum of rat liver, we noticed that W7 had a differential effect on the Ca2+ uptake and Ca2+-ATPase activities. To test the specificity of this effect and explore the underlying mechanism, we examined the effects of W7 on Ca2+ accumulation and release by endoplasmic reticulum in both permeabilized hepatocytes and a subcellular membrane fraction (microsomes) enriched in endoplasmic reticulum. W7 reduced the steady-state Ca2+ accumulation in both preparations in a dose-dependent fashion but the half-maximal inhibitory concentrations were different for Ca2+ accumulation (90 microM) and Ca2+-ATPase activity (500 microM). Kinetic analysis indicated that the inhibition of both Ca2+ uptake and Ca2+-ATPase activity by W7 was noncompetitive with respect to Ca2+ and ATP. Addition of W7 did not enhance the rate of Ca2+ efflux from microsomes after Ca2+ influx had been terminated. The effect of W7 was apparently not related to its calmodulin antagonist properties as the phenomenon could not be demonstrated with the other more specific calmodulin antagonists, calmidazolium or compound 48/80. A similar observation with W7 has also been reported with the endoplasmic reticulum of pancreatic islets (B. A. Wolf, J. R. Colca, and M. L. McDaniel (1986) Biochem. Biophys. Res. Commun. 141, 418-425). We concluded that the effects of W7 on microsomal Ca2+ handling were not the result of increased membrane permeability to Ca2+ but rather were due to dissociation of Ca2+ uptake from Ca2+-ATPase activity.
在首次尝试使用钙调蛋白拮抗剂作为探针来研究钙调蛋白在调节大鼠肝脏内质网钙摄取活性中的作用时,我们注意到W7对钙摄取和钙ATP酶活性有不同的影响。为了测试这种效应的特异性并探索其潜在机制,我们研究了W7对通透化肝细胞和富含内质网的亚细胞膜组分(微粒体)中内质网钙积累和释放的影响。W7以剂量依赖性方式降低了两种制剂中的稳态钙积累,但钙积累(90 microM)和钙ATP酶活性(500 microM)的半数最大抑制浓度不同。动力学分析表明,W7对钙摄取和钙ATP酶活性的抑制作用相对于钙和ATP是非竞争性的。在钙流入终止后,添加W7并没有提高微粒体中钙外流的速率。W7的作用显然与其钙调蛋白拮抗剂特性无关,因为用其他更特异性的钙调蛋白拮抗剂、氯米达唑或化合物48/80无法证明这种现象。关于W7的类似观察也已在胰岛内质网中报道(B. A. Wolf、J. R. Colca和M. L. McDaniel(1986年)《生物化学与生物物理学研究通讯》141,418 - 425)。我们得出结论,W7对微粒体钙处理的影响不是由于膜对钙的通透性增加,而是由于钙摄取与钙ATP酶活性的解离。